Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Xylella fastidiosa 9a5c

>XF2276 peptide synthase
MIGWNGRCHSGGGIQHMKEPCNIAAVLPRLARERPEQIAIRCPGRPGSGG
MAAYDLTLSYRELDRRSDAIAAGFSAYGIGRGVRTVVMVRPSPEFFLLMF
ALFKVGAVPVLVDPGIDRLALKQCLSEAEPQAFIGVFLAQLARRLLRWAP
SVTRVVSVGRWAWCGTTLAHLERAGTGASAQLADTTADEVAAILFTSGST
GVPKGVVYRHRHFVGQIALLRETLSIVPGGVDLPTFPPFALFNPALGLTS
IIPDMDPRCPARADPRKLHDAIARFGVSHLFGSPALLRVLAEYGKPLPTL
RCVTSAGAPVPPQVVAQIRALLPDEAQFLTPYGATECLPVAVIESRELET
TRAATERGAGTCVGHVIAPNLVRIIAIDDEGIEEWGGVREVGLGEIGEMT
VVGPSATDVCYNRTAATRLAKIRERLADGSERIVHRMGDLGYFDAQRRLW
FCGRKTHRVETVQGPLYTEQVEPVFNVIDGVRRTALVGIGALGAQRPVLC
YEALPGVDVAALEQRLRATARAFIHTVGIVDVLRHPGFPVDIRHNAKIGR
ERLAVWATQRLRR
>XF0201 hypothetical protein
MFKTGKSYDHSYFDQWYRQTKLSSPARLRRKVALAVSQAEYYLERPIRSV
LDIGCGEGAWRKPLLRLRPHIHYLGFDSSHYAVNRYGLQRNLHLAQIGDF
SWLRPCAPVDLLVCADVLHYVATRELTRALPGLVELCNGVAFLEIFTAED
AFEGDTTGFQSRQARWYRRRFTAAGFTALGSHCWLSPVLAGHTTALEHN
>XF1639 beta-ketoacyl-[ACP] synthase II
MPPIAITAFTATTAVGHGQAALNEALRTRRSGLRRNDFGVHPLKCWIGDV
EGLETMTLPQALHPWECRNNRLAWLALQQDNFSEAVANARTRHGKTQMAV
IMGTSTSSIGASEEAYTRLEYDAEGARFPDDLQRAVIHAPHSLGNFVQHA
TDLCGPCVTVATACSSSAKVFAQAARLITSGVVSAALVGGVDTLCGSVLF
GFNALQLVSPEPCRPFDVHRAGLSLGEAGGFALLERLDLAPDADLLLCGY
GESSDAYHMSAPHPEGLGARMAMQEALARANVDASEVGYLNLHGTASPAN
DSIEAVAIAALFPPTLHASSTKAWTGHTLGASGIVESTIALLALRGNILP
GTMNSEQLDPVCGPQIRCENAHTPILYAMNNSFGFGGNNCALLFKRADA
>XF0668 hemolysin-type calcium binding protein
MMSNNISVEIRYDVGGVDGIPHTFIVITLPDGTEREYGYGPANPGSRSGP
GTVFETGAHTKEREHEYNTSSSKHSITLDQYNALMDFIELTRQGQKYSLL
GGFSDPNIFNCTTWQVSAFRYAGIRLPSISADRWNPYAQYILDKIERIPI
ISAPSLSELRRMEYENFFEARKFMPRRDPLVLDLDGDGIETVAAGKHILF
DHDGDGIKHASGWVKSDDGFLVLDRNGNGRIDDGSELFGADTVLANGDKA
TSGFEALRDLDSNGDGLFDAADARFADVRVWRDLNQDGQSQANELFTLSS
LGIASITLTPTNTEDVDLGNGNLIDNRGTYTRTDGRTGVVGDLQLGLEHF
YRDYSGAHDKVTVSDAARALPAISGSGAVRDLREAASLSPALLAAVQALT
PGTTRDTMRAALDPLVALWAGTSAMPSTEQRLETSAAVPRTVYYHGAVPA
AVTAQGKEAVQAWIQQQHARLGPIIAILEKFNGSSLVSERNGQVSTGGET
FTWNRVIHPDGHSEDVMSILLQPEQINSLMSAYASLKEFAYAGLVLSTRL
SDYLSGLTLTYSNDAFGWDASALEAKLDHTWQHNKTQALQDVMDLYRYGS
NAVAASGWKPFDALRHMIDRTAATPDGRQALAAAEITLVSGSAEGSTAAD
LIFGDAGANILRGGAGDDVLSGGDGDDTLYGGDGNDTLYGDAGNDTLYGG
GGNDLLLGGDGDDVLDGGEGSNRLEGGAGDDVLKVSYWSADNVLIGGTGD
DTLYGSAFADTYLFNQGDGHDTIIEQGGTDKLVFGEGIVAADVRLLRQGQ
DVVLDLGNGHDSIRLKDWLTSNGTRNHSADIEQIVFADGTLWTPETLSSM
GLTTLGTSGNDTLKGWQGKDILLGGAGDDVLDGGEGSNRLEGGAGNDVLK
VSYWSADNVLIGGTGDDTLYGSAFADTYLFNQGDGHDTIIEQGGTDKLVF
GEGILAADVRLLREGQDVVLDLGNGHDSIRLKDWLTSNGTRNHSADIEQI
VFADGTLWTPETLSSMGLTTLGTPGNDTLKGWQGKDILLGGDGDDVLDGG
EGSNRLEGGAGNDVLKVSYWSADNVLIGGTGDDTLYGSAFADTYLFNKGD
GHDTIIEQSGTDKLVFGEGLHQKEARFTRSGDDLSLLFNGSEDQVTIAGW
FNGSGHQVESLVFQDGTVLSGEVERLIAAMALSPAATTLQASVGDHKESP
RLVASSIV
>XF0913 tropinone reductase
MRTMTQSRWRLDGRTALITGASTGIGLAVARELLGLGADVLLVARNADLL
GRVRDELAEEFPERELHGLAADVADDVDRRAILDWVEDCSNGLHVLINNA
GGNVTRAALEYTEDEWREIFEINLFSAFELCRYTQPLLACHASTAIVNIG
SVSGLTHVRSGVPYGMSKAALHQMTRNLAVEWAEDGIRVNAVAPWYIRTR
RTSEPLSDVYYYEQVIERTPMRRIGEPEEVAAAVAFLCLPASSYVTGECI
AVDGGFMRYGF
>XF1011 hemolysin-type calcium binding protein
MTLTAEQANALLGSITTQEQLRDLINQLDIHSSGSITVLYSGDTANGVSN
SQILQGMLHNGDDIRVIDTTEAAKFLNVDPKDPNSNTALYQKLQQIIGDR
PDRWGSPSNQFLFGERTFDGTRLPNGAWDTISARFVNDTVGEVRTLTGGA
SVNGVFNQTELPRLLNNPNITSVDGLPIADLRRLGVAGSFQAISAQSEHL
SGYLKVAINADGSIMELPGGVPRLDSQQYFALTGLEGKPPLVDAGDYGAL
ARYIPARLDTHLEGARLVQDIKDRYQRTTQLLGPESAAARADALRVLGKL
GVAADLLSLAVMAHDANAAYASGNIEGSRQIVQDWTSAYLGGLMGGLAEA
KAVGLLLTPVYLDGPIGAAVASVLTVAAGVEGTFLGSHYIGAFLDKVFDQ
LHHIGELSGARLYDWVTQIGDLFRRLNQTLHTDNASLLDLLHDLFRNSRD
ERDPLVLDLDGDGIETVAAGKNILFDHDGDGITHASGWVKSDDGLLVLDR
NGNGRIDNGSELFGADTVLANGHKATSGFEALRDLDSNGDGLFNAADARF
TDVRVWRDLNQDGHSQANELFTLSNLGIASITLTPTDTQRVNLGNGNVMD
ARGSYTRTDGRSGTVGNLQLGVDQFYRDYRGAHDTVTISEAARALPAISG
SGAVRDLQEAASLSPALLAAVQALLSGTTQGTLRAALDQVIALWASTSTM
RSSEESLEASGEGHRTVYYHGLVVPGSVASQGEAAVLPWIKEQHARLGPI
IGILEKFNGSRMVSEQNGQISMVGRTFAWQRVVRPDGHSEEAMYLALPPR
QLSATFDAFAEAYAKLKESIYIRLVLEPRLTDYLSGLRLTDNNGVMAWDA
SGLEAKLDQTWQHNKAQALQDVMDLYRYGSNAVAASGWKPFDALRHMIDR
TAATPDGRQALAAAEITLVSGNAEGSDAADLLFGDAGANLLRGGGGDDVL
SGGGGNDTLEGGAGNDTLYGDDGDDVLDGGEGSNRLEGGAGNDVLKVSYW
SADNVLIGGTGDDTLYGSAFADTYLFNQGDGHDTIIEQGGTDKLVFGEGI
LAADVRLLREGQDVVLDLGNGHDSIRLKDWLTSNGTRNHSADIEQIVFAD
GTLWTPETLSSMGLTTLGTPGNDTLKGWQGKDILLGGAGDDVLDGGEGSN
RLEGGAGDDVLKVSYWSADNVLSGGTGDDTLYGSAFADTYLFNQGDGHDT
IIEQGGTDKLVFGEGILAADVRLLREGQDVVLDLGNGHDSIRLKDWLTSN
GTRNHSADIEQIVFADGTLWTPETLSSMGLTTLGTSGNDTLKGWQGKDIL
LGGAGDDVLDGGEGSNRLEGGAGDDVLKVSYWSADNVLIGGTGDDTLYGS
AFADTYLFNKGDGHDTIIEQGGTDKLVFGEGILAADVRLLREGQDVVLDL
GNGHDSIRLKDWLTSNGTRNHSADIEQIVFADGTLWTPETLSSMGLTTLG
TPGNDTLKGWQGKDILLGGDGDDVLDGGEGSNRLEGGAGDDVLKVSYWSA
DNVLSGGTGDDTLYGSAFADTYLFNKGDGHDTIIEQGGTDKLVFGAGLSR
KEARFTRSGDDLSLLFNGSEDQVTVAGWFNGSGHQVESLVFQDGTVLSAE
VERLIAAMALSPAVTTMQASVGETKESPRLVASSIV
>XF1303 conserved hypothetical protein
MYVVSDVKIELRTSRGTGYAYSLIMPTKTVTAPRIEQDAQDRGQIHLSGS
WVLANVLTASELLQSYSNSIQHINARNIDQLDSAGALQLLRFATRTGLKN
DAIGFREEHRPLISTIEILDDEYPKPERDYGFLAALERLGIAVVKTRRNI
VDVCSFLGENLVKIAQLAREPRRFRITSTVHHMEQVGLDAVPLVVVLSYL
VGAVIAFLGSTILRNFGAEIFVVELVNIAFLREFAVLLTAIVLAGRTASA
FTAQIGAMKSREEIDAIQTLGLDPIDLLVIPRLIALLVMLPLLTFIAMIA
GLAGGITVGAFDLGIPPQMYLSRMHETMQFRHFIIGMSKAPLFALIIGLI
GCLEGLKVTGTAQSVGKHTTSSVVQTISLVIIIDALAALWFMRMGW
>XF1794 hypothetical protein
MLVRALILVLVVLNFGVALWWRNQSAPKVPVPVAASSPVGVPQLELLPMI
QVEKPKSLDTPIHKVSTYCYNVGPFTSEADARTVLATLGKDVDKGMIRAL
QSGDSNNYRVVMSASDHASAQALAKRIVGAGFRDYYVLGNEVILGQYRNR
EGAKRMRADLAAAGFQANVLSGDVSGWEIHLRSAIEFAALQVRLNGYHIG
SLDCATLR
>XF1302 ABC transporter ATP-binding protein
MVHAYGLVKLMSKTTTHPIAGEHKETNLAIRVRGLINRFGAQTVHDGLDI
DVHRGEILGVVGGSGTGKSVLMRTILGLRTPNAGSIEVLGVNPHSQTSED
RRIIARNTGVLFQDGALFSSMTVGENVQVPMKEHHGEFPKRLYYELALLK
IKLAGLPANALDKFPSQLSGGMRKRAGLARALALDPPLLFLDEPTAGLDP
IGAASFDQLIKTLQKALGLTVFLITHDLDTLYTICNRVAVLAERKVIANA
PLAEIETIDHPWIREYFHGPRGRAARTAQHTSTGST
>XF0319 acetoacetyl-CoA reductase
MTLRIAYVTSGMGSIGTAICQKLARNGHTVVAGCGPNSPRKANWLREQRE
LGFDFIASEGNAADWDSTVSAFAKVKAEVGEIDVLVNNAGNNRDMLFRQM
GREDWNSVISSNLNSLFNITKQVIDAMTARNWGRIVNIGSVSAHKGQIGQ
VNYATAKAAMHGFTRALAQEVATRNVTVNTISPGYIASAAISSFPPDVLD
RLANSVPMRRLGKAEEVAGLCAWLVSDEAAYVTGADYAVNGGLRME
>XF1772 hypothetical protein
MFADSDQHMPAARVPGCRGSLPRCPPVRIASIPRTRVPVTSMLFINRVRE
LPSREGRGPAFPRSPSMSQQASFGQLALTYCGKFLPLEVLQSAAGHYIGT
RDTEGPVSRESREYFRSYAAAQRALERGGWSQLAIP
>XF2716 ketoreductase
MQDLKKKVILVTGASDGIGKFTAATLAKQGHKLIIHGRNRQKTEAALAEI
KRQSGNPDVAMFLADFLPLAGVKAFADAIKEKYDHIDVLINNAGAQFTEQ
REVTSEGHEKTMAINVFAPMLLTKLLMPLLVKSESARVVTVASDAHRMAG
KPDLDDIELKQGYHMAKAYSLSKLYVIWVMHHFIGETKKAGIHNVTFNLV
HPASTRTNLGREAVKSWKWKIIFFLWQIMLVSMDKAASSTLYAATAPELE
GVSGRYFGPKGEEQPSAKYHSPENEQKVWDYALNAIRPYLPAGAQS
>XF2269 3-alpha-hydroxysteroid dehydrogenase
MNLHNKTMLITGVASGIGSEVARLARFHGATVIGIDCRPVTMTLHGFFHA
DLGDPASIDALIAQLPERIDVLANIAGVPGTVAADLVAKVNYLGLRHLTQ
ALLPRLTPGGNVINMTSLLGAEWPQRLELHKQLAATPDFAAGLDWLAAHP
VSASTCYQYFKEALIVWTMLRSRDWFAEHGVRVNSVAPGPVFTPILGDFV
SMLGPDRVQADASKMKRPSYADEVAEAVIFLACDAARWINGVNLPVDGGL
AATTI
>XF2135 polyketide synthase (PKS)
MHILYRPSPRSGDGLPLIGLCLLTLLIFSRSVAMSSPAIVEIEIWSDVIC
PWCWIGKRRLERALRNSSLFAHIRVRHRAFRLMPELIPLPVIDVLQQRYG
GSAEQIVAMQQRIENIAAEEGLMYRLVGTQGGDTLQAHRLLYLAHRQGLQ
EVLLERFYSAYFSEGTPIFDTDILAPLALDVGLERTAVAALFAGQDFIAE
IEDDQRRLQRYDANGVPFFLMDGRIAVNGAQPIEAFSDALAQLNADSASE
PVLSLH
>XF2082 oxidoreductase
MSNSKVVVITGVSSGIGRATALILAKQGCQVFGTVRNAEKAQAIPGVVLV
EMDIRDDVSVERGIQNIMAQAKRIDVLVNNAGVTLLGATEETSVTEAKTL
FDTNLFGMLCTIQAVLPHMREQRSGRIVNISSVLGFLPAPYMALYSASKH
AVEGLSETLDHEVRQFGIRVALVEPSFTKTNMDLNAPQTASKIPDYSREF
DIVSQAIQKNVQKAPDPEGVASTILNAALGRWKMRHTPKGQASRLAKLRR
FMPAGPIEKGLRKTFGLG
>XF0673 3-oxoacyl-[ACP] synthase II
MNRRVVVTGMGMVSPLGNDLTTSWDGIVHGRSGIAPIVQIDASKLSTQIA
GEIKGFDPMKFVSAKDAKKMDSFIYYGIGAAFMALDDAGLEINEINAERV
GALIGSGIGGVFGIEEQTIKFYEGGVRKISPFYVPSTIINMLPGQLSVLK
GLKGPTFSAVSACATSNHSIGMAMRMIQYGDADVMLAGGSERASSPTAIG
GFCAMRAMSTRNDDPTGASRPWDKGRDGFVLGDGAGILVLEEYEYAKARG
ARIYAELAGFGATSDAFHMTMPVEDGEGAARCMRIALQDAKVTPEQIDYL
NAHGTSTPLGDLCETNAIKTVLGDHAYKVMVSSTKSMTGHLLGAAGGVEA
IFSVMALHTGIVPPTINLEEPDEGCDLDYVPHVAREAKLDVVVSNGFGFG
GTNGTLVFKRI
>XF0356 cytochrome P-450 hydroxylase
MKLADLSSPAFLENPYPLYETLRRQGSFVSIGPNALMTGRYSIVDGLLHN
RNMGKSYMESIRVRYGDDALDMPLFQGFNRMFLMLNPPVHTHLRGLVMQA
FTGRESESMRPLATDTAHRLIDDFEQKSSVDLVTEFSFPLPMRIICRMMD
VDISDAISLSVAVSNIAKVLDPAPMSPDELVHASAAYEELAHYFTRLIEL
RRAQPGTDLISMLLRAEEEGQKLTHDEIVSNVILLLLGGYETTSNMIGNA
LIALHRHPKQLARLKSDLSLMPQAILECLRYDGSVQFTMRAAMDDVSIEG
DVVPRGTIVFLMLGAANRDPAQFTDPDHLDITRKQGRLQSFGAGVHHCLG
YRLALVELECALTVLLERLPHLRLANLDTLSWNQRGNLRGVNALIADLHS
>XF0421 toluene tolerance protein
MILPTPAVQLSGVRIERGGRTVLRNVALQVPRGSITTVLGPSGSGKSTML
AALTGELRPTEGEVRLFGDGIPQGPQALLEMRRNLGVLLQGNGLLTDLSI
AENVALPLRAHTRMPEPLLQRLVLMKLHAVGLRAVAEAMPRELSGGMARR
VALARALALDPPLMIYDEPLTGLDPIASGVIVSLIKRLNDSLGLTTIIVS
HHVHETLPICDQAVVIANSTVIFAGTPAQLEASNDALVHQFMHGQPDGPI
PFDAAPRTYDRSSA
>XF0607 hypothetical protein
MSELISYAQNFEDIMLWRAFKHIDRGCYIDIGAYSPDIDSVSKLFYERGW
RGIHIEPNQECADALRMRRPDELVLQVAVSDLAGVLPFFDIADVGLSTTE
PDIADTHRAHGFVVRDVSVVAITLDAVLEHLRGREVHWLKIDVEGSESRV
LRSWVASPVRPWVVVVEATRPMTVEPTHTQWEAAVLGKGYVFAYFDGLNR
FYVSDRHPELLAGFACPPNVFDGFRLENSWCAVGVRQWDECQKSLIKSQS
DALAAHAEVEALKVSEVVLRQAIEAYRADAIAAYVEVKTLNASKACLQQA
IDVHRTTSEHLIREIDSLRAMLDDIRRSHSWHVTRPLRVFSRIVRLLCRS
PRHAIRECLILAMRPLLRRPGIRALLNGVVKRVPVLHRRLRSLAEQEGLV
APPLSTADVLVSVPVPHVLGQAHRSLACDEKQGMHLLSSRGREIYARMIG
QINKGE
>XF0419 toluene tolerance protein
MRGPRLEFAVGTFLLLTLASLLVLAVASTNQRWSMGGNQYTLTAHFTQIG
QLRKQAPVRISGVNIGQVSNIALDPKTFESVVTLSLDNQYKDLPADTSAN
ILTSGLLGESYINLLPGGDPEVLKPGDQIAFTQPAVDLIQLVGKYMFSGG
SDKSTSSNTTSTTDHAASSHTDTQETHQ
>XF1741 daunorubicin C-13 ketoreductase
MDRRRFLATGAELGSALIAGSLLAATPSWAQTPARKETPMPNVQRGAGRK
ARVFITGSADGLGHAAAKTLLSQGHEVVVHVRSQARMSAVKELVDQGATA
TVGDLSDLAQVRDLARQVNDLGRMDAVIHNAGILSGNQVLVVNVVAPYLL
TALIQRPQRLIYLSSSMHKGGRASLSGMDWTGRTATGSYSDSKLFVTTLA
AAVARLWPEVYSNAVDPGWVPTKMGGAGAPDDLRLGHLTQEWLATSDDPQ
ALTSGGFWHHQRRQEPHSAVNDTRFQDLLLAELARATGTKLAGA
>XF0771 ACP
MLMPDLCAPFIVWGLFQMSVQTPAERELAELIVESLNLEDVQSGEIDPEA
PLFNTGLGLDSIDALELALVITKRYGFQMRSDNDDNQRIFASLRALSDHV
QAHRRT
>XF2677 L-ascorbate oxidase
MNTQKKSLSLYLRNFLLIIVLFVSLQAVAAEKKNDVVNNQKDAFESLLFS
EPPSLKSTLREMLENHFGVEKSPNNHNDVYYVLNIGYVDGKFYDPSSNSF
QKVHLRGYTGQDANNKRVTQVNQFVAPQIEAHPGDTVRILLKNRLPPDAS
CLNNHGMQQQVTANKLADKPHCFNGTNLHAHGLWISPTGNSDNVLLSINP
GVNFEYQYDLSNDIPEGTFWYHPHRHGSTALQVSSGMAGAFIIRGNRKPT
PTSNGDLSTLLMDPETGKSYKEHTVLFQQIAYACRGNDGKLKRKKDGTIN
WSCNPGETGVIESYDQFGPGTWPASGRWTSINGIVLPTFKSQVGEVERWR
LIHAGVRETINMTFRKINPNINLNELHKRAYTGHLKREDAGRLVQELCSG
ETIPFQIVAADGLTMSHTINSQKVTLQPGYRYDLLTVFPSSGGYCIIQPQ
QPKAGSINSESSPQSLLGFVSVSGKDNIPTNAITSVLVNKLIKSAEKFMP
ENVREEVIKDIAHAEGKDNHHEILLRKFTPHPIDIADTEVQDQSKQKLLF
FVGPGPDKNNIFVLSHDFSVKRVNGVYIPSKPFIYNPNKLGLNLPLGKAQ
EWELRSYSVSHPYHIHVNPFQIVAIYDPQGRDVSAPGVVEADGDTQFSGL
KGQWKDTILVKTNLLPGDLKKNPKNFYRFIIRTRYQRYIGEFVLHCHILD
HEDQGMMEKIAISLQDNVDLH
>XF2390 hypothetical protein
MLSARHFFGLNLGLIKINIRDNFFGKNSLKSRLIETLIGLWICTADTYVK
RVTPLFFTPDVERHSGALFNSKDLVILPSAGLIESHSRTFMVPSEALVVR
IGVSV
>XF1397 hypothetical protein
MDMNNLDGQGECGRSDTAFPNFIACGIADAGDATQPFQVKPTFDSVWSND
DGACGNNVLIQRLHVSLREAVAAELPVGARLIDLGCGTGLDAQAFAQRGY
RVMAIDGASAMVAPAHQRAQAVGLEARLQVVPVGIQHIDQLRGEFDGIYS
NFGSLNHIEDLPAVAVECARLLRSDGCLVFSVIGRMCPWEMNEDTLRGRL
MQVSMRFACGAAALRVSGEMVRIRRYLPREFYRVFEAYFSLEYYRPLSVF
LPPPYLVGLYQRYPMLGQSLVWLDDRIATWPLLRDMGDYFLIVMRKRSTC
CYV
>XF0132 copper resistance protein A precursor
MGVSMNTVPFPSQGGIDRRRFLQGLALGGVAAGTGLWRLPVHAANPELPP
LQRRTTPLELRIGQSSVNFTGRMRPAITVNNSLPGPVLRWRQGDTVQIHV
TNTLPDVMTSIHWHGIVLPSNMDGVPGMSFDGIAPGEHYLYRFQLHQSGT
YWYHSHAMFQEQAGLYGALIIDPLEPPPYRADREHILLFSDWTDLDPAAL
FRRLKKMSSYDNTYQRTVRDFFHDIRRDGLRTTLADRRMWGRMRMTPTDL
SDVNAHTYTYLLNGTTPAGAWTGLFRPGEKVLLRLINGSAMTYFDVRIPG
LKLTVVAVDGQYVHPVTVDELRIALAETYDVLIQPHGQDAFAIFAQDMGR
TGYACGTLAVRPGLHAPLPALDPRPRLTMQDMGHGMAHGQHGSRASEMAD
MPGMTHPGRLGDHASHASQPPAQTIPHGSHSLPADRTAPRHPASEQNNPL
VEMHVDAPQPLLNDPGIGLRDNGRHVLTYADLHSLFDDPDGREPGREIEL
HLTGHMEKFAWSFDGIPFASAQPLRLNYGERVRIVLVNDTMMAHPIHLHG
LWSDLEDANAAFQVRKHTIDMPPGTRRSYRVRADALGRWAYHCHMLYHME
SGMMREVQVRP
>XF2099 biotin synthesis protein
MNGLFDTSHIRRAFSRAARSYDTNAILQHEVEQRLLESLDYLGDRIPRVI
LDVGAGTGRASIAMKKRWPKAQVIAFDQAMPMLQEARKRSHWWKPLAQIC
GDARTLPVADASVDVIFSNLCLQWIEDLPTVFAGFRQALRPGGLLLCSLF
GPDTLIELREAFAQADAVPHISPFPSMPQCGDALVLAHFQNPVLDRDLFT
LTYDNLSALMRSLRAIGATNALQERRTTLTGRGRFAATATAYETLRNADN
KLPSSWEVIYACAWAPTSDPMTRENNHEIASIPINSIPIRRRNSS
>XF0671 3-oxoacyl-[ACP] reductase
MNKPLQGEVALVTGASRGIGAAVADLLADHGATVIGTATSVSGAQLIGDR
LALLAGHGRALDVNDTAAVGALVGEIAEQFGSVSILVNNAGITRDNLLMR
MKDEDWESIVDTNLSSIFRTSRAVVRDMMKARKGRIINIASVVGVTGNAG
QANYAAAKAGVIGFTKSLAKEVGPRGITVNVVAPGFIDTDMTRVLSEGVR
NDILNRVPLGHLGDPVDIAHAVAFLAAPAARYITGETLHVNGGMYMP
>XF1301 conserved hypothetical protein
METKANYVLIGSFTILTGLALLIFGLWAAKYSSDRTWQNYRVVFREAVTG
LSVGSPVQYNGIAIGSITQLTLAPNDPRQVIAHIRVNSTTPVKKDTRAKL
AITSLTGPSIIQLSGGTPESPSLTSIYKDDAPIIQTTPSALQNITDTAND
IVERLYDVLSDKNVAAISTILQNMQKISGQVSDSDTGLKALLTSAHDATR
QLNAALATTNGTVQQLDNNLVKQLPVILNKLEATLTKIDATASNANSILD
NNQAAINSFASEGLSQFAPTMSELRNLIRDLRQISNKLEDNPKRYLLGRN
APKEFDPK
>XF2759 hemolysin-type calcium binding protein
MNGYESLYNRYMQEANTYATYYGLDPSTAHNGEWDAFRHAYASGAMTREY
GETAAHLFGDLNEIRGDFIHNQPEYEKNMDKWNNSVGRNIGKDSASSDEI
ARRVYDAMKRGHLITDPWNDTRRYNERNQPDKGNNRDALGDSVGDNSHGT
GAAGGPGAGGASVSKRITPLPPRDPLALDLDGDGIETTGSDGRVILFDHD
ADGVKTGTGWLKPDDGWLVLDRNGNGTIDSGRELFGTDTLKRNGQLATDG
FDALRDVDSNQDGKIDAADRVFANLRIWRDLNQDGISQANELSTLDANHI
VSIGVTATAGRVDLGNGNVQTAAGTFTRSNGTTGATEGTTGTAANLDLLA
DTFYRDFTQQVALTDQAKALPFLRGSGRVRNLDEAISLSKDLGNWVQSYS
QQSTRQAQLDRLDGLMEKWANTSDMQSLRAQAEALASKGVTVTYVLSGLN
PGTAAYQDFLRKLGIVERFMGFTYGGQQGEARFTPLDATSGTMTVSLSDV
QVTNIALAYERFKTDIYESLLLKTRMEPIYNLAEEDFVNGAWVMDWSGVE
RALKQGIQRHPRDGILDAIEFVSALGYKTAERLGWNAIGFLADQLSAAPD
MGAFDHESSSWTVIFAAADRHFITGSARSDVLLGTSGNDMIIGEVTGNDV
LIGKGGNDTLQGGSGDDTLDGGTGNDTLNGGAGNDTYRFAIGAGVDSIYE
DVTATSDTDIVTFADVRSTALTALERKDYDLVIKYGTSDQLTINNYFHPC
YSGAKIEQFTFSDGVTWDDAAIKARVISNGDASNNYLRGYKDGSNRIYGL
DGNDEIYGGALDDMLDGGAGNDMLSGGKGADTLDGGSGNDMLYGGTGNDT
YRFAIGAGVDRIEESDATAGNTDVVRFADVASSALTALERKDSDLVIKYG
TSDQLTISNYFYSAEYKVEQFTFSNGVTWDEAAIKARVISNGDANNNYLV
GYNDGSNRIYGLDGNDTIYGGALDDMLYGGAGNDMLSGGKGADTLDGGSG
NDMLYGGTGNDTYRFAIGAGVDRIEESDATAGNTDVVRFADVAFSALTAL
ERKDSDLVIKYGTSDQLTISNYFYSAEYKVEQFTFSNGVTWDEAAIKARV
ISNGDASNNYLRGYKDGSNRIYGLDGNDEIYGGALDDMLDGGAGNDMLSG
GGGADTLDGGSGNDMLYGGTGNDTYRFAIGAGVDRIEDYDTTTGNADVLS
IGQGVSINQLWFQHVGNDLEVSIIGTGDQITISDWYSNAAYHVEQFKTSD
GKVLRDNQVNALVSAMAGFAPPALGQTSLSTDYQKALNPLIAAHWK
>XF2407 bacteriocin
MMTSLDFYFDQATLDRANTYRNAGNYPAMYQTLSDAVTAGGGDTKLVNWL
TLAGEINSGRRENFYADFVRGAVYHAGSEAGIPIDAALFQHVSDLLARNV
MNDALQNKMLSFDRVISRDVAAASEPVGAGGLGLAMDKWGGTVGGAFPIS
VGGLGMDPNSAFYQNLEKFYRDNGYTPGDRAARLFDLLDDSFFGLIEVAK
NPIAINDLANRITVNTLTRFAIITQRQLDVANIFSGLQGDATQSGSLSEI
VWDNGRNTVTNAGIMLFPVSPLAGVGMQMGINMGMAVAPLVGDVFSGATA
TWNRWMQPLFDQLLDMVRDSIQHGADAVRQTLHDWWTHIGDAFHRLGEKL
HKDSESFTDLLHDLFDQSRDYVTPCDPLALDLDGDGIETVAPGKHILFDH
DGDGIKHASGWVKSDDGLLVLDRNGNGRIDNGNELFGTETVLSNGRKAAS
GFEALRDLDSNADGVFSAADRRFNEVRVWRDLNQDGQSQANELFTLSSLG
IASITLTPTTTPPISMPLGNGNFVGASGIYTRTDGRTGGINDLQLGISRF
YRDNSGAQEQVTVSAAARALPTLKGSGAVRDLQEAASLSPALLAAVQALL
SGTTQGTMRAALDQVIALWASTSTMLSTEERLEASGNSNRTVYYHGWVPG
SVTSQGEAAVQTWIQQQHARLGPIIGILEKFNGSNLVRYNNDAVSTDINV
FHWYHDTMSIRLVDQRQIDPLIEAYAKLKESIYIRLVLEPRLTDYLSGLR
LTYNNGVMAWDASGLEAKLDHTWQHNKAQALQDVMDLYRYSSDALAPSGW
NPLNGLRQMIDKTAATPDGRQALADAGIPLIAGNAEGSDAADLLFGDAGA
NLLRGGGGDDVLSGGDGDDTLYGGDGNDILHGDAGNDTLYGGGGNDLLLG
GDGDDVLDGGEGSNRLEGGAGNDVLKVAYRSADNVLIGGTGDDTLYGSGY
ADTYLFNKGDGHDTIIEKSGDDTLVFGEGIVASQVRVLREGQDVVLDLGN
GHDSIRLKDWLDSNGYRNGNNDIEQIVFADGTIWTPETLSSMGLTTLGTS
GNDTLKGWQGKDILLGGDGDDVLDGGMGSNRLEGGAGNDVLKVAYRSADN
VLIGGTGDDTLYGSAYADTYLFNKGDGHDTIIEQSGDDTLVFGAGIVASQ
VRVLREGQDVVLDLGNGHDSIRLKDWLTSDGYRNGNNDIEQIVFADGTIW
TPETLSSMGLTTLGTSGNDTLKGWQGKDILLGGDGDDVLDGGMGSNRLEG
GAGNDVLKVAYRSADNVLIGGTGDDTLYGSAYADTYLFNKGDGHDTIIEQ
SGDDTLVFGAGIVASQVRVLREGQDVVLDLGNGHDSIRLKDWLTSDGYRN
GNNDIEQIVFADGTIWTPETLSSMGLTTLGTSGNDTLKGWQGKDILLGGD
GDDVLDGGMGSNRLEGGAGNDVLKVAYRSADNVLIGGTGDDTLYGSAYAD
TYLFNKGDGHDTIIEQSGDDTLVFGAGIVASQVRVLREGQDVVLDLGNGH
DSIRLKDWLTSDGYRNGNNDIEQIVFADGTIWTPETLSSMGLTTLGTSGN
DTLKGWQGKDILLGGDGDDVLDGGMGSNRLEGGAGNDVLKVAYRSADNVL
IGGTGDDTLYGSAYADTYLFNKGDGHDTIIEQGGDDTLVFGAGIVASQVR
VLREGQDVVLDLGNGHDSIRLKDWLTSDGYRNGNNDIEQIVFADGTIWTP
ETLSSMGLTTLGTSGNDTLKGWQGKDILLGGDGDDVLDGGMGSNRLEGGA
GNDVLKVAYRSADNVLIGGTGDDTLYGSGYADTYLFNKGDGHDTIIEQGG
DDTLVFGAGIVASQVRVLREGQDVVLDLGNGHDSIRLKDWLTSDGYRNGN
NDIEQIVFADGTIWTPETLSSMGLTTLGTSGNDTLKGWQGKDILLGGDGD
DVLDGGMGSNRLEGGAGNDVLKVAYRSADNVLIGGTGDDTLYGSAYADTY
LFNKGDGHDTIIEQGGDDTLVFGAGLHQKEARFTKSGNDLSILFNASEDQ
VTIAGWFNGSGHQVESLVFQDGTVLSGEVERLIAAMALSSAVTTTQASVR
DTKESHRLVASSIV
>XF0287 regulator of pathogenicity factors
MSQTRPWLQHYPSGISTEIDTDAFRTIADVFDTSVIKYRHCPAYTNFGKT
LTYGEVDLLTKQFASYLLNVLKLKKGDRIALMMLNCLQYPVATFGALCAG
LTVVNVNPLYTARELKHQLVDAGSTVLVVMDNFCTTVQQIIADTPIKQVI
TTELGDLLDFPKRSLINFAVKHIKKLVPEYQLPRSIRFREALALGSKHSM
PPIHIASDDLAFLQYTGGTTGTPKGAMLTHRNMVANMQQVSQWLQTSNSL
KEGCETVLTALPLYHIFALTANSLVFMKIGGCNHLISNPRNMRTFVKELQ
RVRFTVITGVNTLFNKLLNTPGFDKLDFSSLKIALGGGMVIQRSVAEQWK
QVTHVPLIEAYGLTEASPEACINPLNLQEHNGSIGMPIPSTDVCIKDDTN
TALPIGEMGELCIKGPQVMKGYWQRPEETSEVLDADGWLHTGDIVKMDKQ
GFLYIIDRKKEIILVSGFNVYPKEIEEVIAMIPGVAEVAAVGVPDEQSGE
VVKVVIVKKDPMLTAEEVKAHAATNLTRYKLPRIIEFRATLPKTDVGKIL
RRELRDAAPASTTFTAQPK
>XF2274 hypothetical protein
MEHLMHPENVALIVVDLQPDFMPGGALPCEEGASIVPGIAALLDARQYST
IVATQDWHPADHVSFTAQQPFEQITLHDQP
>XF0672 ACP
MRSDKPMSDIEARVRKIVAEKLNVDEEKVTNTSTFVDELGADSLDTVELV
MALEDEFQCEIGDEAAEKMTSVQHAIDYIKSNAKC
>XF0377 cytochrome P450-like enzyme
MKLTDLSNPAFLENPYPLYETLRAQAPFVSIGPNALMTGRYSLVDSLLHN
RNMGKKYMESMRVRYGDSAADMPLFQAFSRMFITINPPAHTHLRGLVMQA
FTGRESESMRPLAIDTAHQLIDNFEQKPSVDLVAEFAFPFPMQIICKMMD
VDIGDAVTLGIAVSKIAKVFDPSPMSADELVHASTAYEELAQYFTKLIEL
RRTHPGTDLISMFLRAEEDGEKLTHDEIVSNVIMLLIAGYETTSNMIGNA
LIALHRHPEQLALLKSDLSLMPQAVSECLRYDGSVQFTMRAAMDDIEVEG
ELVPRGTVVFLMLGAANRDPAQFTHPDQLDITRKQGRLQSFGAGIHHCLG
YRLALIELECALTTLFERLPHLRLAHLDALNWNQRSNLRGVNTLIVDLHA
KN
>XF0418 toluene tolerance protein
MKTTLFYIMFAYALSTAFPSMMLAQASSIAEVNQGQASKMVIDSSARVLS
TLEQQRAQFRQDPKALRQFMETEFTTIFDRDYAARLVLGKYARNASDTDV
KLFADAITENLMQRYGNALLTFEGKPNFRAKSESRLPGNRNVRVSTELIR
SGADPVAVDYLLRNVNGQWKIFDVMIEGISYVQTFRNQFDAPLRQKGIAQ
VAAELRSGNLQVGKSNGK
>XF1726 2,5-dichloro-2,5-cyclohexadiene-1,4-dioldehydrog enase
MNPTYDFKGQVALVTGAAAGMGLATARGFAQGGASVVLADRDGERAAQEA
AAIVAEGGTAIGLACDVSDEAQVAALVEKTVAEYGRLDFAFNNAGVMAKI
APFAEATSEEFDRVIGINLRGVWLCMKYELQQMQRQGSGVIVNNASVGAL
TGNVGIGAYIASKHGVLGLTRAAALEYCKKGIRVNAVNPGTIDTQIARDV
VGGSDEAFAKLGASAPIGRAGRPEEIASAVLWLCSPGGSYVIGEGLTVDG
GYVVP
>XF0173 3-oxoacyl-[ACP] reductase
MEHVSMITDNSPRFRALVTGGSGHLGTAICRQLIADGAHVIVHANHHRSR
ADTLVECLCAEGGSAEVIVFDVTAAQASKTALENLLQTGPIQIIINNAGI
HDDAPMAGMSSTQWHRVIDVSLHGFFNVTQPLLLPMARTRWGRIVCISSV
TAVLGNRGQSNYAAAKAGLHGAARSLAREMANRGITVNVVAPGVIESEMV
GKTFTPEMIKQLVPTGRPGRPEEVAALIGFLCSEKAGYINGQVIGINGGM
G
>XF1457 pteridine reductase 1
MSDPSKVALITGGARRIGKAIVHHLHAHGYRVAVHAHQSGHELHAFLTEL
ERTRPSSTLALLGDLHENAVPEMLIARCAGHFGRLDVLINNASNFYPTPL
GEVTPAQWDDLFAINAKAPFFLAQAATPLLRKHRGAIINLTDLHGTQPLR
RHAVYTAAKAALEMLTRSLALELAPQVRVNAIAPGAILWPTQGIAEAAKQ
ALLARTPLARTGTVEEIAEAVLWLLESANFITGHTLRLDGGRTLT
>XF0420 toluene tolerance protein
MPLVSSISSLGRSGLFALTVLRSSLPTRDFFAELIREIYKIGARSLPIIA
VGGAFVGLVLTLQGYRTLTLYGASDALSTLLGLSLYRELAPVLTALLFIG
RAGSSVAAELSLMRATDQIKALELMAIDPIAKAVAPRFWAAILTVPLLTG
VFCSLAICSGYFQAVHVLGIDNGLFWSGLSNSVDFLEDFGVAMLKSAIFG
GTSALVAAYVGFHAQPTIEGTSIATTRAVVNASLLVLMFNFVLSALLFR